Annual ROE:
-52.59%-22.00%(-71.92%)Summary
- As of today, TRVI annual return on equity is -52.59%, with the most recent change of -22.00% (-71.92%) on December 31, 2024.
- During the last 3 years, TRVI annual ROE has risen by +100.44% (+65.63%).
- TRVI annual ROE is now -182.58% below its all-time high of 63.68%, reached on December 1, 2016.
Performance
TRVI ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-45.24%+14.46%(+24.22%)Summary
- As of today, TRVI quarterly return on equity is -45.24%, with the most recent change of +14.46% (+24.22%) on June 30, 2025.
- Over the past year, TRVI quarterly ROE has increased by +2.54% (+5.32%).
- TRVI quarterly ROE is now -181.17% below its all-time high of -16.09%, reached on December 1, 2017.
Performance
TRVI Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TRVI ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1Y1 Year | -71.9% | +5.3% |
3Y3 Years | +65.6% | +66.0% |
5Y5 Years | +38.6% | +18.0% |
TRVI ROE Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
---|---|---|---|---|---|
3Y | 3-Year | -71.9% | +65.6% | -70.4% | +41.1% |
5Y | 5-Year | -71.9% | +65.6% | -70.4% | +77.9% |
All-Time | All-Time | -182.6% | +73.1% | -181.2% | +77.9% |
TRVI ROE History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | -45.24%(+24.2%) |
Mar 2025 | - | -59.70%(+5.4%) |
Dec 2024 | -52.59%(-71.9%) | -63.10%(-5.3%) |
Sep 2024 | - | -59.95%(-25.5%) |
Jun 2024 | - | -47.78%(-25.6%) |
Mar 2024 | - | -38.03%(-24.7%) |
Dec 2023 | -30.59%(+34.7%) | -30.50%(-14.9%) |
Sep 2023 | - | -26.55%(+7.7%) |
Jun 2023 | - | -28.77%(+20.5%) |
Mar 2023 | - | -36.18%(+24.2%) |
Dec 2022 | -46.82%(+69.4%) | -47.73%(+37.9%) |
Sep 2022 | - | -76.83%(+42.2%) |
Jun 2022 | - | -132.96%(+35.1%) |
Mar 2022 | - | -204.75%(-17.2%) |
Dec 2021 | -153.03% | -174.67%(-15.7%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | -151.01%(-24.3%) |
Jun 2021 | - | -121.46%(-29.0%) |
Mar 2021 | - | -94.15%(-17.4%) |
Dec 2020 | -80.07%(+6.6%) | -80.18%(-28.0%) |
Sep 2020 | - | -62.62%(-13.5%) |
Jun 2020 | - | -55.15%(+10.0%) |
Mar 2020 | - | -61.30%(+5.0%) |
Dec 2019 | -85.70%(+56.1%) | -64.52%(+6.8%) |
Sep 2019 | - | -69.22%(+13.1%) |
Jun 2019 | - | -79.61%(+51.8%) |
Mar 2019 | - | -165.32%(+4.7%) |
Dec 2018 | -195.42%(-124.6%) | -173.50%(-254.4%) |
Jun 2018 | - | -48.96%(-204.3%) |
Dec 2017 | -87.02%(-236.7%) | - |
Dec 2017 | - | -16.09% |
Dec 2016 | 63.68% | - |
FAQ
- What is Trevi Therapeutics, Inc. annual return on equity?
- What is the all-time high annual ROE for Trevi Therapeutics, Inc.?
- What is Trevi Therapeutics, Inc. annual ROE year-on-year change?
- What is Trevi Therapeutics, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Trevi Therapeutics, Inc.?
- What is Trevi Therapeutics, Inc. quarterly ROE year-on-year change?
What is Trevi Therapeutics, Inc. annual return on equity?
The current annual ROE of TRVI is -52.59%
What is the all-time high annual ROE for Trevi Therapeutics, Inc.?
Trevi Therapeutics, Inc. all-time high annual return on equity is 63.68%
What is Trevi Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, TRVI annual return on equity has changed by -22.00% (-71.92%)
What is Trevi Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of TRVI is -45.24%
What is the all-time high quarterly ROE for Trevi Therapeutics, Inc.?
Trevi Therapeutics, Inc. all-time high quarterly return on equity is -16.09%
What is Trevi Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, TRVI quarterly return on equity has changed by +2.54% (+5.32%)